A second plausible explanation may be potential insufficiency of protective AHR ligands in the AD patient environment (possibly due to imbalance of microbial-produced ligands or dietary molecules), leading to the retention of AHR outside of the nucleus. Here, AHR is linked to Alzheimer disease.